2007 CARTILAGE BIOLOGY & PATHOLOGY GORDON RESEARCH CONFERENCE
2007 CARTILAGE BIOLOGY & PATHOLOGY GORDON RESEARCH CONFERENCE
批准号:
7386300
负责人:
HENRY M. KRONENBERG
金额:
$0.3万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-15 至 2007-08-31
关键词:
AdultAgeAttentionBiochemistryBiologyBiomechanicsCartilageChondrocytesDataDegenerative polyarthritisDevelopmentDiagnosisElasticityEnsureEventEvolutionFaceGene ExpressionGenetic Predisposition to DiseaseHandHuman GeneticsHuman PathologyHypertrophyJointsLeftMechanicsMetabolicMinorityModelingMolecularMolecular and Cellular BiologyOccupationalOperative Surgical ProceduresOrganismOrthopedicsOsteoarthrosis DeformansPathogenesisPathologyPharmaceutical PreparationsPhasePrevention therapyPropertyReplacement ArthroplastyResearchRiskScientistSeminalSenior ScientistShapesSkeletal DevelopmentSkeletonStagingTimeTissue EngineeringTissuesTodayTransgenic AnimalsWomancell typeinterestprogramsskeletal disordersymposiumtissue culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Worldwide increasing interest and the fascination which cartilage research is receiving today has to do
with the two faces of cartilage: On the one hand, cartilage is a permanent tissue of outstanding biomechanical
properties in the adult organism, providing joints with elasticity and high mechanical stability and ensuring
mobility. On the other hand, cartilage has evolved in evolution as a transient tissue, shaping a model of the
skeleton. Osteoarthritis (OA) and other degenerative joint diseases are not an inevitable fate coming with age.
Several decades of research have shown ample evidence for genetic predisposition and for environmental or
occupational risk for developing osteoarthritis. Nevertheless, there is still insufficient progress in understanding
the pathogenesis of OA, including mechanisms of cartilage destruction and joint remodeling. As a result, there
is only slow progress in the development of medication for prevention, therapy and diagnosis of OA in early
phases, leaving joint replacement operations as the final therapy in late stages.
With the recognition that degeneration and remodeling events in OA cartilage reflect changes in
differentiation, gene expression and metabolic activities of the articular chondrocyte, the biology of this cell
type has been moving to the center of research focus. Major progress in our understanding problems of
cartilage degeneration, hypertrophy and remodeling in osteoarthritic joints has come from basic studies using
tissue culture and transgenic animals. Strong evidence shows that the molecular mechanisms responsible for
these events are very similar to mechanisms regulating chondrocyte differentiation, maturation and
endochondral ossification in skeletal development This overlap of regulatory phenomena was a major
rationale for the first two Gordon Conferences on cartilage biology. These two very successful conferences on
cartilage biology brought together, for the first time, the fields of skeletal development, biochemistry,
biomechanics, cell- and molecular biology of cartilage with the fields of cartilage pathology, human genetics of
skeletal disorders, orthopedic research and tissue engineering.
In setting up the program for the third conference, special attention is being paid to offer young
scientists and minorities the chance to present and discuss their new data. But it was also felt that the
conference would not be successful without the seminal and highly motivating contributions of the leading
senior scientists in this field who had been instrumental in shaping the format and scientific level of the
previous conferences. Special attention has been given to assure that the meeting takes full advantage of
substantial representation of woman scientists as speakers and session chairs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of osteoblast progenitors in response to bone anabolic agents
-
批准号:10404415
-
项目类别:
-
资助金额:$92.4万
-
财政年份:2023
-
负责人:HENRY M. KRONENBERG
-
依托单位:
PTH actions on early cells of the osteoblast lineage
-
批准号:10207597
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2020
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Administrative Core
-
批准号:10451721
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2019
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Administrative Core
-
批准号:10183170
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2019
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Administrative Core
-
批准号:10626807
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2019
-
负责人:HENRY M. KRONENBERG
-
依托单位:
CENTER FOR SKELETAL RESEARCH
-
批准号:9285601
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2014
-
负责人:HENRY M. KRONENBERG
-
依托单位:
CENTER FOR SKELETAL RESEARCH
-
批准号:8853820
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2014
-
负责人:HENRY M. KRONENBERG
-
依托单位:
CENTER FOR SKELETAL RESEARCH
-
批准号:8693238
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2014
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Genetic Analysis of Second Messengers in PTH Signaling in Bone
-
批准号:7627067
-
项目类别:
-
资助金额:$39.62万
-
财政年份:2008
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Functions of PTH/PHTrP Receptor, PTHrP and PTH in vivo
-
批准号:7432428
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2007
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:7325709
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2006
-
负责人:HENRY M. KRONENBERG
-
依托单位:
2007 CARTILAGE BIOLOGY & PATHOLOGY GORDON RESEARCH CONFERENCE
-
批准号:7218758
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2006
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Specialized Center for Cell Based Therapy
-
批准号:7126374
-
项目类别:
-
资助金额:$210.08万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Functions of PTH/PHTrP Receptor, PTHrP and PTH in vivo
-
批准号:6946563
-
项目类别:
-
资助金额:$41.35万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Specialized Center for Cell Based Therapy
-
批准号:7690371
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:7160506
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Specialized Center for Cell Based Therapy
-
批准号:7282059
-
项目类别:
-
资助金额:$218.94万
-
财政年份:2005
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:7062733
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2004
-
负责人:HENRY M. KRONENBERG
-
依托单位:
Role of PLC in PTH Signaling: Mutant Receptors in Vivo
-
批准号:6744652
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2003
-
负责人:HENRY M. KRONENBERG
-
依托单位:
OSTEOBLAST SPECIFIC ABLATION OF THE PTH/PTHRP RECEPTOR
-
批准号:6660896
-
项目类别:
-
资助金额:$28.21万
-
财政年份:2002
-
负责人:HENRY M. KRONENBERG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: